NWI Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
NWI Management's XBI Position: Q2 2018 in Review
NWI Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2018, closing a stake of 600,000 shares — an estimated $52.6M sold.
NWI Management first reported a position in XBI in Q1 2018 and held it in 1 quarter. The position peaked at $52.6M in Q1 2018. 431 funds tracked by Wall St. Rank hold XBI as of Q2 2018.
- NWI Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2018 after selling out during the quarter.
- NWI Management sold 600,000 State Street SPDR S&P Biotech ETF shares in Q2 2018, an estimated $52.6M.
- NWI Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and held it in 1 quarter.
- NWI Management's State Street SPDR S&P Biotech ETF position peaked at $52.6M in Q1 2018.
- 431 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2018.
Based on NWI Management's 13F filing for Q2 2018, filed 14 Aug 2018.